Bazemore Robert Binsider trades
In SEC Form 4 filings, Bazemore Robert B is listed as Director of Akari Therapeutics Plc (AKTX). Bazemore Robert B reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AKTXAkari Therapeutics Plc | Director | 8 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 773 | $0.00 | $0 | 19,666 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M | 3,093 | $0.00 | $1 | 22,759 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 773 | $16.16 | $12,492 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 14 | Oct 16 | M · derivative | 3,093 | $16.16 | $49,983 | not reported | No | Form 4 |
| AKTXAkari Therapeutics Plc | Oct 5 | Oct 16 | A | 4,677 | $7.90 | $36,944 | 18,893 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A | 13,100 | $7.90 | $103,477 | 14,216 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 45,000 | $7.90 | $355,455 | 45,000 | No | Form 4 |
| AKTXAkari Therapeutics Plc | Aug 18 | Oct 16 | A · derivative | 15,000 | $7.90 | $118,485 | 15,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.